Zepp Health: A Meme Stock Or Serious Play?
Zepp's revenue grew 78.5% in Q3, but forecasted growth slows to 40%. Company approaches profitability after reducing reliance on Xiaomi. Stock has soared over 10 times since July despite recent 25% drop. Zepp's P/S ratio remains modest at 3.98, indicating potential undervaluation. Need for product improvements highlighted as user reviews show mixed reactions.
View signal analysis